Campto - Irinotecan Injection

Get a Price/Quote

Product Details:

Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Product Description

Campto - Irinotecan Injection:-

CAMPTO is indicated for the treatment of patients with advanced colorectal cancer:

In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease,
As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.

CAMPTO in combination with is indicated for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, KRAS wild-type metastatic colorectal cancer, who had not received prior treatment for metastatic disease or after failure of irinotecan-including cytotoxic therapy (please see 5.1).

CAMPTO in combination with 5-fluorouracil, folinic acid and bevacizumab is indicated for first-line treatment of patients with metastatic carcinoma of the colon or rectum.

Campto in combination with capecitabine with or without bevacizumab is indicated for first-line treatment of patients with metastatic colorectal carcinoma.